Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1973 1
1981 1
1986 1
1987 1
1988 2
1989 2
1991 1
1992 1
1994 2
1995 2
1996 2
1997 2
1998 1
2000 3
2001 3
2002 2
2003 2
2004 3
2005 3
2007 2
2008 1
2009 1
2010 1
2011 4
2012 1
2014 3
2015 6
2016 5
2017 3
2018 6
2019 4
2020 4
2021 7
2022 5
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging.
Muresan ID, Agoston-Coldea L. Muresan ID, et al. Heart Fail Rev. 2021 Sep;26(5):1023-1036. doi: 10.1007/s10741-020-09931-1. Heart Fail Rev. 2021. PMID: 32040801 Review.
Hypertrophic cardiomyopathy (HCM) is the most common cardiovascular disease with genetic transmission, characterized by the hypertrophy of any segment of the left ventricle (LV), not totally explained by improper loading conditions, with LV systolic function preserv …
Hypertrophic cardiomyopathy (HCM) is the most common cardiovascular disease with genetic transmission, characterized by the hy …
The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms.
Andrade J, Khairy P, Dobrev D, Nattel S. Andrade J, et al. Circ Res. 2014 Apr 25;114(9):1453-68. doi: 10.1161/CIRCRESAHA.114.303211. Circ Res. 2014. PMID: 24763464 Review.
Atrial fibrillation (AF) is the most common arrhythmia (estimated lifetime risk, 22%-26%). The aim of this article is to review the clinical epidemiological features of AF and to relate them to underlying mechanisms. ...Emerging risk factors include prehypertension, increa …
Atrial fibrillation (AF) is the most common arrhythmia (estimated lifetime risk, 22%-26%). The aim of this article is to review the c …
The role of amiodarone in contemporary management of complex cardiac arrhythmias.
Mujović N, Dobrev D, Marinković M, Russo V, Potpara TS. Mujović N, et al. Pharmacol Res. 2020 Jan;151:104521. doi: 10.1016/j.phrs.2019.104521. Epub 2019 Nov 19. Pharmacol Res. 2020. PMID: 31756386 Review.
Amiodarone is a potent coronary and peripheral vasodilator and can be safely used in patients with left ventricular dysfunction after myocardial infarction or those with congestive heart failure or hypertrophic cardiomyopathy. Its use is regularly accompanied with Q …
Amiodarone is a potent coronary and peripheral vasodilator and can be safely used in patients with left ventricular dysfunction after myocar …
Atrial Fibrillation in Hypertrophic Cardiomyopathy.
Vaidya K, Semsarian C, Chan KH. Vaidya K, et al. Heart Lung Circ. 2017 Sep;26(9):975-982. doi: 10.1016/j.hlc.2017.05.116. Epub 2017 May 23. Heart Lung Circ. 2017. PMID: 28602671 Review.
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disorder with a spectrum of clinical manifestations. ...
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disorder with a spectrum of clinical manifestations. ...
Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
Providencia R, Elliott P, Patel K, McCready J, Babu G, Srinivasan N, Bronis K, Papageorgiou N, Chow A, Rowland E, Lowe M, Segal OR, Lambiase PD. Providencia R, et al. Heart. 2016 Oct 1;102(19):1533-43. doi: 10.1136/heartjnl-2016-309406. Epub 2016 May 27. Heart. 2016. PMID: 27234160 Review.
OBJECTIVE: Atrial fibrillation (AF) is common in hypertrophic cardiomyopathy (HCM) and is associated with a high risk of stroke. ...Freedom from AF/atrial tachycardia relapse was higher in patients without HCM (after a single procedure: 38.7% HCM vs 49.8% controls, …
OBJECTIVE: Atrial fibrillation (AF) is common in hypertrophic cardiomyopathy (HCM) and is associated with a high risk of strok …
Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment.
Pagourelias ED, Alexandridis GM, Vassilikos VP. Pagourelias ED, et al. Heart Fail Rev. 2021 Nov;26(6):1297-1310. doi: 10.1007/s10741-020-10058-6. Epub 2021 May 15. Heart Fail Rev. 2021. PMID: 33990907 Review.
Hypertrophic cardiomyopathy (HCM) represents one of the primary cardiomyopathies and may lead to heart failure and sudden cardiac death. ...
Hypertrophic cardiomyopathy (HCM) represents one of the primary cardiomyopathies and may lead to heart failure and sudden card …
Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
Adamczak DM, Oko-Sarnowska Z. Adamczak DM, et al. Cardiol Rev. 2018 May/Jun;26(3):145-151. doi: 10.1097/CRD.0000000000000184. Cardiol Rev. 2018. PMID: 29621050 Review.
Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by hypertrophy of the left ventricular myocardium and is most often caused by mutations in sarcomere genes. ...
Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by hypertrophy of the left ventricular myocardium and is mo …
Novel Pharmacotherapy in Hypertrophic Cardiomyopathy.
Andries G, Yandrapalli S, Naidu SS, Panza JA. Andries G, et al. Cardiol Rev. 2018 Sep/Oct;26(5):239-244. doi: 10.1097/CRD.0000000000000211. Cardiol Rev. 2018. PMID: 29746257 Review.
Hypertrophic cardiomyopathy (HCM) is an inherited disease characterized by unexplained left ventricular hypertrophy. ...
Hypertrophic cardiomyopathy (HCM) is an inherited disease characterized by unexplained left ventricular hypertrophy. ...
Designing phase II clinical trials in Friedreich ataxia.
Rodden LN, Lynch DR. Rodden LN, et al. Expert Opin Emerg Drugs. 2021 Dec;26(4):415-423. doi: 10.1080/14728214.2021.1998452. Epub 2021 Dec 22. Expert Opin Emerg Drugs. 2021. PMID: 34693848 Review.
FRDA most notably affects the heart, sensory neurons, spinal cord, cerebellum, and other brain regions, and manifests clinically as ataxia, sensory loss, dysarthria, spasticity, and hypertrophic cardiomyopathy. Therapeutic approaches in FRDA have consisted of two di …
FRDA most notably affects the heart, sensory neurons, spinal cord, cerebellum, and other brain regions, and manifests clinically as ataxia, …
Myocardial bridging.
Alegria JR, Herrmann J, Holmes DR Jr, Lerman A, Rihal CS. Alegria JR, et al. Eur Heart J. 2005 Jun;26(12):1159-68. doi: 10.1093/eurheartj/ehi203. Epub 2005 Mar 11. Eur Heart J. 2005. PMID: 15764618 Review.
83 results